GabriellaD'AndreaMD

PubMed

• Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast Cancer.
  Patrick G. Morris, Selene Rota, Karen Anne Cadoo, Stephen Zamora, Sujata Patil, Gabriella D'Andrea, Theresa Gilewski, Jacqueline Bromberg, Chau T. Dang, Maura N. Dickl...> ;Clinical Breast Cancer. 2018 Oct 1
• Hidden estrogen production from ovarian remnants leading to progression of disease in metastatic breast cancer.
  Ashley Weiner, Gabriella D'Andrea> ;Breast Journal. 2018 Jan 22
• A phase I trial of ganetespib in combination with paclitaxel and trastuzumab in patients with human epidermal growth factor receptor-2 (HER2)-positive metastatic breas...
  Jhaveri, K., Wang, R., Teplinsky, E., Chandarlapaty, S., Solit, D. B., Cadoo, K., Speyer, J. L., D'Andrea, G., Adams, S., Patil, S., Haque, S., O'Neill, T., Friedman, ...> ;Breast cancer research : BCR. 2017 Aug 3
• A Pilot Study of Dose-Dense Paclitaxel With Trastuzumab and Lapatinib for Node-negative HER2-Overexpressed Breast Cancer.
  Iyengar, N. M., Fornier, M. N., Sugarman, S. M., Theodoulou, M., Troso-Sandoval, T. A., D'Andrea, G. M., Drullinsky, P. R., Gajria, D., Goldfarb, S. B., Comen, E. A., ...> ;Clinical breast cancer. 2015 Oct 12
• Phase II Study of Paclitaxel Given Once per Week Along With Trastuzumab and Pertuzumab in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Br...
  Chau T. Dang, Neil M. Iyengar, FM Datko, Gabriella D'Andrea, Maria Theodoulou, Maura N. Dickler, Shari Goldfarb, Diana Lake, Julie Fasano, Monica Fornier, Theresa Gile...> ;Journal of Clinical Oncology. 2015 Feb 10
• 5 citations
  A phase II open-label study of ganetespib, a novel heat shock protein 90 inhibitor for patients with metastatic breast cancer.
  Komal Jhaveri, Sarat Chandarlapaty, Diana Lake, Teresa Gilewski, Mark E. Robson, Shari Goldfarb, Pamela Drullinsky, Steven Sugarman, Carolyn Wasserheit-Leiblich, Julie...> ;Clinical Breast Cancer. 2014 Jun 1
• Phase II trial of a novel capecitabine dosing schedule in combination with lapatinib for the treatment of patients with HER2-positive metastatic breast cancer.
  Gajria, D., Gonzalez, J., Feigin, K., Patil, S., Chen, C., Theodoulou, M., Drullinsky, P., D'Andrea, G., Lake, D., Norton, L., Hudis, C. A., Traina, T. A.> ;Breast cancer research and treatment. 2011 Sep 8
• 11 citations
  HSP90 Inhibition Is Effective in Breast Cancer: A Phase II Trial of Tanespimycin (17-AAG) Plus Trastuzumab in Patients with HER2-Positive Metastatic Breast Cancer Prog...
  Shanu Modi, Alison T. Stopeck, Hannah M. Linden, David B. Solit, Sarat Chandarlapaty, Neal Rosen, Gabriella D'Andrea, Maura N. Dickler, Mary Ellen Moynahan, Steven Sug...> ;Clinical Cancer Research. 2011 Aug 1
• TBCRC 011: Targeting the androgen receptor (AR) for the treatment of AR+/ER-/PR- metastatic breast cancer (MBC).
  Gucalp A, Tolaney SM, Isakoff SJ, Ingle JN, Liu MC, Carey LA, Blackwell KL, Rugo HS, Nabell L, Abbruzzi A, Gonzalez J, Giri DD, Patil S, Feigin K, D'Andrea G, Theodoul...> ;J. Clin. Oncol.. 2011-05-20
• Perfusion CT in solid body-tumours. Part II: Clinical applications and future development.
  Bellomi M, Viotti S, Preda L, D'Andrea G, Bonello L, Petralia G> ;Radiol Med. 2010-09-01
• CT perfusion in solid-body tumours. Part I: Technical issues.
  Petralia G, Preda L, D'Andrea G, Viotti S, Bonello L, De Filippi R, Bellomi M> ;Radiol Med. 2010-09-01
• Phase II trial of weekly nanoparticle albumin-bound paclitaxel with carboplatin and trastuzumab as first-line therapy for women with HER2-overexpressing metastatic bre...
  Alison Katherine Conlin, Andrew D. Seidman, Ariadne M. Bach, Diana Lake, Maura N. Dickler, Gabriella D'Andrea, Tiffany A. Traina, Michael A. Danso, Adam Brufsky, Manso...> ;Clinical Breast Cancer. 2010 Aug 1
• CT perfusion in oncology: how to do it.
  Petralia G, Bonello L, Viotti S, Preda L, d'Andrea G, Bellomi M> ;Cancer Imaging. 2010-02-11
• Intra- and interobserver agreement and impact of arterial input selection in perfusion CT measurements performed in squamous cell carcinoma of the upper aerodigestive ...
  Petralia G, Preda L, Raimondi S, D'Andrea G, Summers P, Giugliano G, Chiesa F, Bellomi M> ;AJNR Am J Neuroradiol. 2009-06-01
• Role of perfusion computed tomography (CTp) for pretherapy assessment and induction chemotherapy monitoring (IC) in patients with squamous cell carcinoma (SCC) of the ...
  Petralia G, Preda L, Chiesa F, Nolè F, d'Andrea G, Giugliano G, Verri E, Cossu Rocca M, Bellomi M> ;J. Clin. Oncol.. 2009-05-20
• Dose-dense (DD) cyclophosphamide, methotrexate, and fluorouracil (CMF) at 14-day intervals: A pilot study of every 14- and 10-11-day dosing intervals for women with ea...
  Drullinsky P, Fornier MN, Sugarman S, D'Andrea G, Troso-Sandoval T, Seidman AD, Yuan J, Patil S, Norton L, Hudis C> ;J. Clin. Oncol.. 2009-05-20
• A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effects
  Gary Deng, Hong Lin, Andrew D. Seidman, Monica Fornier, Gabriella D'Andrea, Kathleen M. Wesa, Simon Yeung, Susanna Cunningham-Rundles, Andrew J. Vickers, Barrie R. Cas...> ;Journal of Cancer Research and Clinical Oncology. 2009 Mar 1
• Prolonged Dose-Dense Epirubicin and Cyclophosphamide Followed by Paclitaxel in Breast Cancer Is Feasible
  Chau T. Dang, Gabriella D'Andrea, Diana Lake, Steve Sugarman, Monica Fornier, Mary Ellen Moynahan, Theresa Gilewski, Arti Hurria, Nancy Mills, Tiffany A. Troso-Sandova...> ;Clinical Breast Cancer. 2008 Oct 1
• Phase II study of weekly nanoparticle albumin bound (nab)paclitaxel with carboplatin and trastuzumab as 1st-line therapy for HER2-positive metastatic breast cancer (MBC).
  Seidman AD, Conlin AK, Bach A, Brufsky AM, Saleh MN, Lake D, Dickler MN, D'Andrea G, Traina TA, Hudis CA> ;J. Clin. Oncol.. 2008-05-20
• Phase II trial of patupilone in patients (pts) with breast cancer brain metastases (BCBM) progressing or recurring after whole brain radiation therapy (WBXRT).
  Conlin AK, D'Andrea G, Hudis CA, Robson ME, Drullinsky P, Theodoulou M, Lis E, Kang TY, Peereboom DM, Seidman AD> ;J. Clin. Oncol.. 2008-05-20
• A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients.
  Deng G, Smith-Jones HL, Seidman AD, Fornier M, D'Andrea G, Wesa K, Cunningham-Rundles S, Yeung KS, Vickers A, Cassileth BR> ;J. Clin. Oncol.. 2008-05-20
• 64 citations
  Randomized, Controlled Trial of Acupuncture for the Treatment of Hot Flashes in Breast Cancer Patients
  Gary Deng, Andrew J. Vickers, K. Simon Yeung, Gabriella D'Andrea, Han Xiao, Alexandra S. Heerdt, Steven Sugarman, Tiffany A. Troso-Sandoval, Andrew D. Seidman, Cliffor...> ;Journal of Clinical Oncology. 2007 Dec 10
• 3 citations
  Increased dose density is feasible: a pilot study of adjuvant epirubicin and cyclophosphamide followed by paclitaxel, at 10- or 11-day intervals with filgrastim suppor...
  Fornier, M. N., Seidman, A. D., Lake, D., D'Andrea, G., Bromberg, J., Robson, M. E., Van Poznak, C., Panageas, K. S., Atienza, M., Norton, L., Hudis, C. A.> ;Clinical cancer research : an official journal of the American Association for Cancer Research. 2007 Jan 4
• Pharmacokinetics and toxicity of weekly docetaxel in older patients.
  Arti Hurria, Mark D. Fleming, Sharyn D. Baker, Wm. Kevin Kelly, Katie Cutchall, Katherine S. Panageas, James Caravelli, Henry Yeung, Mark G. Kris, Jorge Gomez, Vincent...> ;Clinical Cancer Research. 2006 Oct 15
• 6 citations
  A phase I study of cetuximab/paclitaxel in patients with advanced-stage breast cancer.
  Modi, S., D'Andrea, G., Norton, L., Yao, T., Caravelli, J., Rosen, P. P., Hudis, C. A., Seidman, A. D.> ;Clinical breast cancer. 2006 Sep 1
• Join now to see all